Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience
Authors:
- 1 October 2016
- journal article
- Published by Elsevier in Auris Nasus Larynx
- Vol. 43 (5) , 551-555
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)Clinical Endocrinology, 2011
- Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patientsEuropean Journal of Surgical Oncology, 2007
- Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centreSurgery, 2007
- The Occurrence and the Type of Germline Mutations in theRETGene in Patients with Medullary Thyroid Carcinoma and Their Unaffected Kindred's from Central PolandCancer Investigation, 2007
- Analysis of Inherited Genetic Variants in ret Proto-Oncogene of Brazilian Patients with Apparently Sporadic Medullary Thyroid CarcinomaThyroid®, 2006
- Prognostic Factors in Well-Differentiated Follicular-Derived Carcinoma and Medullary Thyroid CarcinomaThyroid®, 2001
- Novel Point Mutations and Allele Loss at the RET Locus in Sporadic Medullary Thyroid CarcinomasJapanese Journal of Cancer Research, 1998
- Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTCOncogene, 1997
- Progress in genetic screening of multiple endocrine neoplasia type 2A: Is calcitonin testing obsolete?*Surgery, 1995
- Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinomaClinical Endocrinology, 1995